Skip to main content

RED TEMATICA DE EXCELENCIA DE INVESTIGACION EN HIPOXIA

SAF2017-90794-REDT

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Redes Investigación /Redes Excelencia
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

HIF1α suppresses tumor cell proliferation through inhibition of aspartate biosynthesis

  • Meléndez-Rodríguez, Florinda
  • Urrutia, Andrés A.
  • Lorendeau, Doriane
  • Rinaldi, Gianmarco
  • Roche, Olga
  • Böğürcü-Seidel, Nuray
  • Ortega-Muelas, Marta
  • Mesa-Ciller, Claudia
  • Turiel, Guillermo
  • Bouthelier, Antonio
  • Hernansanz-Agustín, Pablo
  • Elorza, Ainara
  • Escasany, Elia
  • Yang Li, Qilong Oscar
  • Torres-Capelli, Mar
  • Tello, Daniel
  • Fuertes, Esther
  • Fraga, Enrique
  • Martínez-Ruiz, Antonio
  • Pérez, Belén
  • Giménez-Bachs, José M.
  • Salinas-Sánchez, Antonio S.
  • Acker, Till
  • Sánchez-Prieto, Ricardo
  • Fendt, Sarah-Maria
  • De Bock, Katrien
  • Aragonés, Julián
Cellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate biosynthesis to control cell growth remain largely unknown. Hypoxia-inducible factor-1α (HIF1α) can suppress tumor cell proliferation. Here, we discovered that HIF1α acts as a direct repressor of aspartate biosynthesis involving the suppression of several key aspartate-producing proteins, including cytosolic glutamic-oxaloacetic transaminase-1 (GOT1) and mitochondrial GOT2. Accordingly, HIF1α suppresses aspartate production from both glutamine oxidation as well as the glutamine reductive pathway. Strikingly, the addition of aspartate to the culture medium is sufficient to relieve HIF1α-dependent repression of tumor cell proliferation. Furthermore, these key aspartate-producing players are specifically repressed in VHL-deficient human renal carcinomas, a paradigmatic tumor type in which HIF1α acts as a tumor suppressor, highlighting the in vivo relevance of these findings. In conclusion, we show that HIF1α inhibits cytosolic and mitochondrial aspartate biosynthesis and that this mechanism is the molecular basis for HIF1α tumor suppressor activity., This work was supported by grants from Ministerio de Economia y Competitividad (SAF2016-76815 and SAF2017-90794-REDT) and Fundació La Marató de TV3 (534/C/2016). F.M.-R. is supported by Ministerio de Economia y Competitividad (BES-2014-068618). A.A.U is supported by the CAM “Atracción de Talento” program. D.L. is supported by the VIB-Marie Curie omics program. S.-M.F. acknowledges funding support from a Marie Curie CIG, FWO Odysseus II, FWO Research Grants, Eugène Yourassowsky Schenking, and KU Leuven Methusalem co-funding. O.R. has a contract for accessing the Spanish System of Science, Technology and Innovation (SECTI) funded by the University of Castilla-La Mancha (UCLM). R.S.P acknowledges funding support from Ministerio de Educación y Ciencia (SAF2015-64215-R) and Fundacion Leticia Castillejo Castillo. A.M.-R. acknowledges funding support from Ministerio de Economía y Competitividad (PI15/00107)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Refocusing the brain: New approaches in neuroprotection against ischemic injury

  • Rodríguez González, Cristina
  • Agulla, Jesús
  • Delgado-Esteban, María
A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to review the studies existing to date based in neuroprotection against oxidative stress, which have undoubtedly contributed to clarify the brain endogenous mechanisms, as well as to identify possible therapeutic targets or biomarkers in stroke and other neurological diseases. The efficacy of exogenous administration of neuroprotective compounds has been shown in different studies so far. However, something must be missing to get these treatments successfully applied in the clinical environment. Here, the mechanisms involved in neuronal protection against physiological level of ROS and the main neuroprotective signaling pathways induced by excitotoxic and ischemic stimuli are reviewed. Also, the endogenous ischemic tolerance in terms of brain self-protection mechanisms against subsequent cerebral ischemia is revisited to highlight how the preconditioning has emerged as a powerful tool to understand these phenomena. A better understanding of endogenous defense against exacerbated ROS and metabolism in nervous cells will therefore aid to design pharmacological antioxidants targeted specifically against oxidative damage induced by ischemic injury, but also might be very valuable for translational medicine., This publication was made possible by funding from the Instituto de Salud Carlos III (PI18/00103 and RD16/0019/0018); European Regional Development Fund (FEDER); Junta de Castilla y León (IES007P17; Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León 14-20); and HypoxiaNet (SAF2017-90794-REDT)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Sobrino, Tomás
  • Castillo, José
  • Bolaños, Juan P.
  • Almeida, Angeles
Failure of neurons to efficiently repair DNA double-strand breaks (DSBs) contributes to cerebral damage after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder is unknown. Here, we found that DSBs in oxygen/glucose-deprived (OGD) neurons spatiotemporally correlated with the up-regulation of WRAP53 (WD40-encoding p53-antisense RNA), which translocated to the nucleus to activate the DSB repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSBs and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results indicate that WRAP53 fosters DNA repair and neuronal survival to promote functional recovery after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018 to A.A., RD16/0019/0001 to J.C., and CPII17/00027 to T.S.), European Regional Development Fund (FEDER) to Ministerio de Ciencia en Innovación (SAF2016-78114-R and RED2018-102576-T to J.P.B. and SAF2017-90794-REDT to A.A.), CIBERFES (CB16/10/00282 to J.P.B.), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009 to A.A.), Junta de Castilla y León (IES007P17 to A.A. and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León to A.A. and J.P.B.), Fundación Ramón Areces (to A.A. and J.P.B.), and Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Brain neovascularization mediated by p53 signaling pathway determines functional recovery after intracerebral hemorrhage

  • Rodríguez González, Cristina
  • Martínez-Peralta, S.
  • Carabias-Carrasco, Mónica
  • Resch-Beusher, Monica
  • Prieto, Estefanía
  • Almeida, Angeles
Trabajo presentado en el European Stroke Organisation and the World Stroke Organization 2020 Virtual Conference (ESO-WSO), celebrado online del 7 al 9 de noviembre de 2020, Background And Aims: Brain neovascularization has been associated with good prognosis of intracerebral hemorrhage (ICH) patients. We previously showed that the human Tp53 Arg72Pro SNP modulates brain endothelial cells survival after ICH, which is essential for the secretion of growth factors and cytokines (i.e. VEGF) that mediate the mobilization of endothelial progenitor cells (EPCs) from the bone marrow to the peripheral blood. EPCs promote brain vascular repair after ICH. Then, pro-apoptotic p53 would be a negative regulator of EPC mobilization, thus affecting the functional outcome after ICH. Since p53 is accumulated in the brain after ICH, we speculate that p53 destabilization not only will promote cell survival, but also vascular recovery and brain repair. Methods: p53 KO mice were subjected to an experimental model of ICH in vivo by injecting bacterial collagenase into the basal ganglia. Proliferative markers and perfusion status of newly-formed brain blood vessels in the brain was also analyzed by Evans blue injection. Results: We observed that p53 loss reduced lesion volume and increased levels of circulating EPCs. As a consequence, an improved vascular response was achieved in p53 KO mice, in comparison with those expressing an active p53 protein. Conclusions: Our results point out the impact of the p53 signaling pathway in the balance between brain damage and repair, which might condition functional recovery after ICH., Funded by ISCIII(PI18/00265; RD16/0019/0018), FEDER, EU Horizon 2020 Research and Innovation Programme (Grant Agreement 686009), Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y Leon 14–20); RedHYPOX (SAF2017-90794-REDT)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Non-productive angiogenesis disassembles Aß plaque-associated blood vessels

  • Álvarez-Vergara, María I.
  • Rosales-Nieves, Alicia E.
  • March Díaz, Rosana
  • Rodriguez-Perinan, Guiomar
  • Lara-Ureña, Nieves
  • Ortega-de San Luis, Clara
  • Sánchez García, Manuel A.
  • Martín Bórnez, Miguel
  • Gómez-Gálvez, Pedro
  • Vicente-Munuera, Pablo
  • Fernández-Gómez, Beatriz
  • Marchena, Miguel A.
  • Bullones-Bolanos, Andrea S.
  • Dávila, José C.
  • González-Martínez, Rocio
  • Trillo-Contreras, José Luis
  • Sánchez-Hidalgo, Ana C.
  • Toro, Raquel del
  • Scholl, Francisco G.
  • Herrera, Eloisa
  • Trepel, Martin
  • Körbelin, Jakob
  • Escudero, Luis M.
  • Villadiego, Javier
  • Echevarría, Miriam
  • Castro Soubriet, Fernando de
  • Gutiérrez, Antonia
  • Rábano, Alberto
  • Vitorica, Javier
  • Pascual Bravo, Alberto
The human Alzheimer’s disease (AD) brain accumulates angiogenic markers but paradoxically, the cerebral microvasculature is reduced around Aß plaques. Here we demonstrate that angiogenesis is started near Aß plaques in both AD mouse models and human AD samples. However, endothelial cells express the molecular signature of non-productive angiogenesis (NPA) and accumulate, around Aß plaques, a tip cell marker and IB4 reactive vascular anomalies with reduced NOTCH activity. Notably, NPA induction by endothelial loss of presenilin, whose mutations cause familial AD and which activity has been shown to decrease with age, produced a similar vascular phenotype in the absence of Aß pathology. We also show that Aß plaque-associated NPA locally disassembles blood vessels, leaving behind vascular scars, and that microglial phagocytosis contributes to the local loss of endothelial cells. These results define the role of NPA and microglia in local blood vessel disassembly and highlight the vascular component of presenilin loss of function in AD., A.E.R.-N. was the recipient of a JdlC-F fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness (MINEICO) (FJCI-2015-23708), M.I.A.-V., N.L.-U., and C.O.-d.S.L. were the recipient of an FPU fellowship from Spanish Ministry of Education, Culture, and Sport (respectively, FPU15/02898, FPU14-02115, and AP2010‐1598), and R.M.-D. was the recipient of a “Sara Borrell” fellowship from ISCIII (CD09/0007). Work was supported by grants to A.P. by the Spanish MINEICO, ISCIII, and FEDER (SAF2012‐33816, SAF2015‐64111‐R, RTI2018-096629-B-100, SAF2017-90794-REDT, and PIE13/0004), by the regional Government of Andalusia (“Proyectos de Excelencia”, P12‐CTS‐2138 and P12‐CTS‐2232) co-funded by CEC and FEDER funds, and by the “Ayuda de Biomedicina 2018”, Fundación Domingo Martínez; J.Vitorica: Instituto de Salud Carlos III (ISCiii) of Spain, co-financed by FEDER funds from European Union (PI18/01556) by La Marató-TV3 Foundation grant 20141431; by CIBERNED (CB06/05/0094); and by Junta de Andalucia Consejería de Economía y Conocimiento through grant US-1262734; A.G.: Instituto de Salud Carlos III (ISCiii) of Spain, co-financed by FEDER funds from European Union, through grant PI18/01557; and by Junta de Andalucia Consejería de Economía y Conocimiento through grants UMA18-FEDERJA-211 and P18-RT-2233 co-financed by Programa Operativo FEDER 2014-2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Hypoxia compromises the mitochondrial metabolism of Alzheimer’s disease microglia via HIF1

  • March Díaz, Rosana
  • Lara-Ureña, Nieves
  • Romero-Molina, Carmen
  • Heras-Garvin, Antonio
  • Ortega de San Luis, Clara
  • Álvarez-Vergara, María I.
  • Sánchez García, Manuel A.
  • Sánchez-Mejias, Elisabeth
  • Dávila, José C.
  • Rosales-Nieves, Alicia E.
  • Forja, Cristina
  • Navarro-Garrido, Victoria
  • Gómez-Arboledas, Ángela
  • Sánchez-Mico, María V.
  • Viehweger, Adrian
  • Gerpe, Almudena
  • Hodson, Emma J.
  • Vizuete, Marisa
  • Bishop, Tammie
  • Serrano-Pozo, Alberto
  • López-Barneo, José
  • Berra, Edurne
  • Vitorica, Javier
  • Pascual Bravo, Alberto
Genetic Alzheimer’s disease (AD) risk factors associate with reduced defensive amyloid β plaque-associated microglia (AβAM), but the contribution of modifiable AD risk factors to microglial dysfunction is unknown. In AD mouse models, we observe concomitant activation of the hypoxia-inducible factor 1 (HIF1) pathway and transcription of mitochondrial-related genes in AβAM, and elongation of mitochondria, a cellular response to maintain aerobic respiration under low nutrient and oxygen conditions. Overactivation of HIF1 induces microglial quiescence in cellulo, with lower mitochondrial respiration and proliferation. In vivo, overstabilization of HIF1, either genetically or by exposure to systemic hypoxia, reduces AβAM clustering and proliferation and increases Aβ neuropathology. In the human AD hippocampus, upregulation of HIF1α and HIF1 target genes correlates with reduced Aβ plaque microglial coverage and an increase of Aβ plaque-associated neuropathology. Thus, hypoxia (a modifiable AD risk factor) hijacks microglial mitochondrial metabolism and converges with genetic susceptibility to cause AD microglial dysfunction., R.M.-D. was the recipient of a Sara Borrell fellowship from Instituto de Salud Carlos III (ISCIII) (CD09/0007). N.L.-U., C.O.-d.S.L., C.R.-M. and M.I.A.-V. were the recipients of FPU fellowships from Spanish Ministry of Education, Culture and Sport (FPU14/02115, AP2010‐1598, FPU16/02050 and FPU15/02898, respectively). A.H.-G. was the recipient of an FPI fellowship from the Spanish Ministry of Education, Culture and Sport (BES-2010-033886). This work was supported by grants from the Spanish MINEICO, ISCIII and FEDER (European Union) (SAF2012‐33816, SAF2015‐64111‐R, SAF2017-90794-REDT and PIE13/0004 to A.P.); by the Regional Government of Andalusia co-funded by CEC and FEDER funds (European Union) (‘Proyectos de Excelencia’; P12‐CTS‐2138 and P12‐CTS‐2232 to A.P.); by the ‘Ayuda de Biomedicina 2018’, Fundación Domingo Martínez (to A.P.) ; by the ISCIII of Spain, co-financed by FEDER funds (European Union) through grants PI18/01556 (to J.V.) and PI18/01557 (to A. Gutierrez); by Junta de Andalucía, co-financed by FEDER funds (grants UMA18-FEDERJA-211 (to A. Gutierrez) and US‐1262734 (to J.V.)); and by Spanish MINEICO (BFU2016-76872-R and BES-2011-047721 to E.B.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Preconditioning-Activated AKT Controls Neuronal Tolerance to Ischemia through the MDM2–p53 Pathway

  • Barrio, Emilia
  • Vecino, Rebeca
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Suarez-Pindado, Alberto
  • Bolaños, Juan P.
  • Almeida, Angeles
  • Delgado-Esteban, María
One of the most important mechanisms of preconditioning-mediated neuroprotection is the attenuation of cell apoptosis, inducing brain tolerance after a subsequent injurious ischemia. In this context, the antiapoptotic PI3K/AKT signaling pathway plays a key role by regulating cell differentiation and survival. Active AKT is known to increase the expression of murine double minute-2 (MDM2), an E3-ubiquitin ligase that destabilizes p53 to promote the survival of cancer cells. In neurons, we recently showed that the MDM2–p53 interaction is potentiated by pharmacological preconditioning, based on subtoxic stimulation of NMDA glutamate receptor, which prevents ischemia-induced neuronal apoptosis. However, whether this mechanism contributes to the neuronal tolerance during ischemic preconditioning (IPC) is unknown. Here, we show that IPC induced PI3K-mediated phosphorylation of AKT at Ser473, which in turn phosphorylated MDM2 at Ser166. This phosphorylation triggered the nuclear stabilization of MDM2, leading to p53 destabilization, thus preventing neuronal apoptosis upon an ischemic insult. Inhibition of the PI3K/AKT pathway with wortmannin or by AKT silencing induced the accumulation of cytosolic MDM2, abrogating IPC-induced neuroprotection. Thus, IPC enhances the activation of PI3K/AKT signaling pathway and promotes neuronal tolerance by controlling the MDM2–p53 interaction. Our findings provide a new mechanistic pathway involved in IPC-induced neuroprotection via modulation of AKT signaling, suggesting that AKT is a potential therapeutic target against ischemic injury., This research was funded by the Instituto de Salud Carlos III (PI18/00103 to M.D.-E.; PI18/00285 and RD16/0019/0018 to A.A.; CB16/10/00282 to J.P.B.), MICINN (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T to J.P.B.; SAF2017-90794-REDT to A.A.), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03; CSI151P20), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.), Fundación Ramón Areces (to A.A.P. and J.P.B.), European Regional Development Fund, and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009 to A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke

  • Almeida, Angeles
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
Stroke is a major cause of death and long-term disability in the adult. Neuronal apoptosis plays an essential role in the pathophysiology of ischemic brain damage and impaired functional recovery after stroke. The tumor suppressor protein p53 regulates key cellular processes, including cell cycle arrest, DNA repair, senescence, and apoptosis. Under cellular stress conditions, p53 undergoes post-translational modifications, which control protein localization, stability, and proapoptotic activity. After stroke, p53 rapidly accumulates in the ischemic brain, where it activates neuronal apoptosis through both transcriptional-dependent and -independent programs. Over the last years, subcellular localization of p53 has emerged as an important regulator of ischemia-induced neuronal apoptosis. Upon an ischemic insult, p53 rapidly translocates to the mitochondria and interacts with B-cell lymphoma-2 family proteins, which activate the mitochondrial apoptotic program, with higher efficacy than through its activity as a transcription factor. Moreover, the identification of a human single nucleotide polymorphism at codon 72 of the Tp53 gene that controls p53 mitochondrial localization and cell susceptibility to apoptosis supports the important role of the p53 mitochondrial program in neuronal survival and functional recovery after stroke. In this article, we review the relevance of mitochondrial and nuclear localization of p53 on neuronal susceptibility to cerebral ischemia and its impact on functional outcome of stroke patients., Consejería de Educación, Junta de Castilla y León, Grant/Award Numbers: CLU-2017-03, CSI151P20; EU Horizon 2020Research and Innovation Programme,Grant/Award Number: GA 686009;Ministerio de Ciencia e Innovación,Grant/Award Number:SAF2017-90794-REDT to AA; Junta deCastilla y León; Horizon 2020; EuropeanUnion; European Regional DevelopmentFund; Instituto de Salud Carlos III, Grant/Award Numbers: PI18/00265,RD16/0019/0018
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis

  • López-Fabuel, Irene
  • García-Macia, Marina
  • Buondelmonte, Constantina
  • Burmistrova, Olga
  • Bonora, Nicoló
  • Alonso-Batán, Paula
  • Morant Ferrando, Brenda
  • Vicente-Gutiérrez, Carlos
  • Jimenez-Blasco, Daniel
  • Quintana-Cabrera, Ruben
  • Fernández, Emilio
  • Llop Roig, Jordi
  • Ramos-Cabrer, Pedro
  • Sharaireh, Aseel
  • Guevara-Ferrer, Marta
  • Fitzpatrick, Lorna M.
  • Thompton, Christopher D.
  • McKay, Tristan R.
  • Storch, Stephan
  • Medina, Diego L.
  • Mole, Sara E
  • Fedichev, Peter O.
  • Almeida, Angeles
  • Bolaños, Juan P.
CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. CLN7/MFSD8 gene encodes a lysosomal membrane glycoprotein, but the biochemical processes affected by CLN7-loss of function are unexplored thus preventing development of potential treatments. Here, we found, in the Cln7∆ex2 mouse model of CLN7 disease, that failure in autophagy causes accumulation of structurally and bioenergetically impaired neuronal mitochondria. In vivo genetic approach reveals elevated mitochondrial reactive oxygen species (mROS) in Cln7∆ex2 neurons that mediates glycolytic enzyme PFKFB3 activation and contributes to CLN7 pathogenesis. Mechanistically, mROS sustains a signaling cascade leading to protein stabilization of PFKFB3, normally unstable in healthy neurons. Administration of the highly selective PFKFB3 inhibitor AZ67 in Cln7∆ex2 mouse brain in vivo and in CLN7 patients-derived cells rectifies key disease hallmarks. Thus, aberrant upregulation of the glycolytic enzyme PFKFB3 in neurons may contribute to CLN7 pathogenesis and targeting PFKFB3 could alleviate this and other lysosomal storage diseases., This work was funded by the European Regional Development Fund, European Union’s Horizon 2020 Research and Innovation Programme (BATCure grant No. 666918 to J.P.B., S.E.M., D.L.M., S.S., and T.R.M.; PANA grant No. 686009 to A.A.), Agencia Estatal de Investigación (PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T to J.P.B.; SAF2017-90794-REDT to A.A.), Instituto de Salud Carlos III (CB16/10/00282 to J.P.B.; PI18/00285; RD16/0019/0018 to A.A.), Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03 to J.P.B. and A.A.), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA (to J.P.B.), and Fundación Ramón Areces (to J.P.B. and A.A.). SM benefits from MRC funding to the MRC Laboratory for Molecular Cell Biology University Unit at UCL (award code MC_U12266B) towards lab and office space. Part of this work was funded by Gero Discovery L.L.C. M.G.M. is an ISCIII-Sara Borrel contract recipient (CD18/00203).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Oxidative stress-triggered nuclear WRAP53 translocation promotes neuronal survival and functional recovery after stroke

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Bolaños, Juan P.
  • Almeida, Angeles
Trabajo presentado en la 20th Biennial Meeting of The Society for Free Radical Research International (SFRR-I) celebrada online del 15 al 18 de marzo de 2021, Ischemic stroke is the leading cause of neurologic death and long-term adult disability worldwide. Ischemia-induced oxidative stress compromises genome integrity, resulting in DNA damage. Failure of neurons to efficiently repair DNA double-strands breaks (DSB) contributes to cerebral damage and impairs functional recovery after stroke. However, the molecular machinery that regulates DNA repair in this neurological disorder remains unknown. Here we describe that WRAP53 (WD40 encoding RNA Antisense to p53), a scaffold protein implicated in telomere elongation and DNA repair in tumor cells, plays an essential role in neuronal survival after ischemia. We found that experimental ischemia, performed by oxygen and glucose deprivation (OGD), promoted oxidative stress-induced DSB in neurons. These events spatiotemporally correlated with WRAP53 upregulation and nuclear translocation to activate DSBs repair response. Mechanistically, OGD triggered a burst in reactive oxygen species that induced both DSB and translocation of WRAP53 to the nucleus to promote DNA repair, a pathway that was confirmed in an in vivo mouse model of stroke. Noticeably, nuclear translocation of WRAP53 occurred faster in OGD neurons expressing the Wrap53 human nonsynonymous single-nucleotide polymorphism (SNP) rs2287499 (c.202C>G). Patients carrying this SNP showed less infarct volume and better functional outcome after stroke. These results provide a new signaling role for reactive oxygen species in the mechanism of DSB repair in neurons and unravel the role of WRAP53 to maintaining genome integrity and survival after stroke., This work was funded by the Instituto de Salud Carlos III (PI18/00265 and RD16/0019/0018), European Regional Development Fund (FEDER), Ministerio de Ciencia en Innovación (SAF2017-90794-REDT), European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17 and Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León), and Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition

  • Morant Ferrando, Brenda
  • Jimenez-Blasco, Daniel
  • Alonso-Batán, Paula
  • Agulla, Jesús
  • Lapresa, Rebeca
  • Garcia-Rodriguez, Dario
  • Yunta-Sanchez, Sara
  • López-Fabuel, Irene
  • Fernández, Emilio
  • Carmeliet, Peter
  • Almeida, Angeles
  • García-Macia, Marina
  • Bolaños, Juan P.
Having direct access to brain vasculature, astrocytes can take up available blood nutrients and metabolize them to fulfil their own energy needs and deliver metabolic intermediates to local synapses. These glial cells should be, therefore, metabolically adaptable to swap different substrates. However, in vitro and in vivo studies consistently show that astrocytes are primarily glycolytic, suggesting glucose is their main metabolic precursor. Notably, transcriptomic data and in vitro studies reveal that mouse astrocytes are capable of mitochondrially oxidizing fatty acids and that they can detoxify excess neuronal-derived fatty acids in disease models. Still, the factual metabolic advantage of fatty acid use by astrocytes and its physiological impact on higher-order cerebral functions remain unknown. Here, we show that knockout of carnitine-palmitoyl transferase-1A (CPT1A)—a key enzyme of mitochondrial fatty acid oxidation—in adult mouse astrocytes causes cognitive impairment. Mechanistically, decreased fatty acid oxidation rewired astrocytic pyruvate metabolism to facilitate electron flux through a super-assembled mitochondrial respiratory chain, resulting in attenuation of reactive oxygen species formation. Thus, astrocytes naturally metabolize fatty acids to preserve the mitochondrial respiratory chain in an energetically inefficient disassembled conformation that secures signalling reactive oxygen species and sustains cognitive performance., We acknowledge the technical assistance of M. Resch, M. Carabias-Carrasco, L. Martin and E. Prieto-Garcia, from the University of Salamanca. This work was funded by the European Regional Development Fund, Agencia Estatal de Investigación (grant nos. PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018‐102576‐T to J.P.B. and SAF2017-90794-REDT to A.A.), Instituto de Salud Carlos III (grant nos. CB16/10/00282 to J.P.B. and PI18/00285 and RD16/0019/0018 to A.A.), Junta de Castilla y León (grant no. CS/151P20) and Escalera de Excelencia (grant no. CLU-2017-03 to J.P.B. and A.A.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Microglia mitochondrial complex I deficiency during development induces glial dysfunction and early lethality

  • Mora-Romero, Bella
  • Capelo-Carrasco, Nicolas
  • Pérez-Moreno, Juan J.
  • Álvarez-Vergara, María I.
  • Trujillo-Estrada, Laura
  • Romero-Molina, Carmen
  • Romero-Molina, Carmen
  • Morano-Catalan, Noelia
  • Vizuete, Marisa
  • López-Barneo, José
  • Nieto-González, J.
  • García-Junco-Clemente, Pablo
  • Vitorica, Javier
  • Gutiérrez, Antonia
  • Macías, David
  • Rosales-Nieves, Alicia E.
  • Pascual Bravo, Alberto
Primary mitochondrial diseases (PMDs) are associated with pediatric neurological disorders and are traditionally related to oxidative phosphorylation system (OXPHOS) defects in neurons. Interestingly, both PMD mouse models and patients with PMD show gliosis, and pharmacological depletion of microglia, the innate immune cells of the brain, ameliorates multiple symptoms in a mouse model. Given that microglia activation correlates with the expression of OXPHOS genes, we studied whether OXPHOS deficits in microglia may contribute to PMDs. We first observed that the metabolic rewiring associated with microglia stimulation in vitro (via IL-33 or TAU treatment) was partially changed by complex I (CI) inhibition (via rotenone treatment). In vivo, we generated a mouse model deficient for CI activity in microglia (MGcCI). MGcCI microglia showed metabolic rewiring and gradual transcriptional activation, which led to hypertrophy and dysfunction in juvenile (1-month-old) and adult (3-month-old) stages, respectively. MGcCI mice presented widespread reactive astrocytes, a decrease of synaptic markers accompanied by an increased number of parvalbumin neurons, a behavioral deficit characterized by prolonged periods of immobility, loss of weight and premature death that was partially rescued by pharmacologic depletion of microglia. Our data demonstrate that microglia development depends on mitochondrial CI and suggest a direct microglial contribution to PMDs., B.M.-R. was the recipient of a ‘Junta de Andalucía’ predoctoral fellowship (2021), N.C.-C., M.I.A.-V. and E.M.M. were each the recipients of an FPU/FPI fellowship from the Spanish Ministry of Education (FPU20/03320, FPU15/02898 and PRE2019-087729) and J.J.P.-M. and A.E.R.-N. were the recipients of JdlC-I and JdlC-F fellowships from MCIN/AEI/ 10.13039/501100011033 (IJC2019-038819-I and FJCI-2015-23708). A.E.R.N. is funded by VII PPIT-US. This work was supported by grants to A.P., J.V., A.G. and D.M. by MCIN/AEI/ 10.13039/501100011033, ISCIII (FORT23/00008 (to A.P.); PI21/00915 (to J.V.); and PI21/00915 (to A.G.), and FEDER (RTI2018-096629-B-100, PID2021-126894OB-I00 ‘y por FEDER Una manera de hacer Europa’, SAF2017-90794-REDT, and PIE13/0004), by the regional Government of Andalusia (‘Proyectos de Excelencia’ P12‐CTS‐2138, P20_01312; BIOT22_00018_1, and ProyExcel_00845) co-funded by CEC, REC_EU and FEDER funds, and by the ‘Ayuda de Biomedicina 2018’, Fundación Domingo Martínez., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Weak neuronal glycolysis sustains cognition and organismal fitness

  • Jimenez-Blasco, Daniel
  • Agulla, Jesús
  • Lapresa, Rebeca
  • García-Macia, Marina
  • Bobo-Jimenez, Veronica
  • Garcia-Rodriguez, Dario
  • Manjarres-Raza, Israel
  • Fernandez, Emilio
  • Jeanson, Yannick
  • Khoury, Spiro
  • Portais, Jean-Charles
  • Padro, Daniel
  • Ramos-Cabrer, Pedro
  • Carmeliet, Peter
  • Almeida, Angeles
  • Bolaños, Juan P.
The energy cost of neuronal activity is mainly sustained by glucose1,2. However, in an apparent paradox, neurons modestly metabolize glucose through glycolysis3-6, a circumstance that can be accounted for by the constant degradation of 6-phosphofructo-2-kinase-fructose-2,6-bisphosphatase-3 (PFKFB3)3,7,8, a key glycolysis-promoting enzyme. To evaluate the in vivo physiological importance of this hypoglycolytic metabolism, here we genetically engineered mice with their neurons transformed into active glycolytic cells through Pfkfb3 expression. In vivo molecular, biochemical and metabolic flux analyses of these neurons revealed an accumulation of anomalous mitochondria, complex I disassembly, bioenergetic deficiency and mitochondrial redox stress. Notably, glycolysis-mediated nicotinamide adenine dinucleotide (NAD+) reduction impaired sirtuin-dependent autophagy. Furthermore, these mice displayed cognitive decline and a metabolic syndrome that was mimicked by confining Pfkfb3 expression to hypothalamic neurons. Neuron-specific genetic ablation of mitochondrial redox stress or brain NAD+ restoration corrected these behavioural alterations. Thus, the weak glycolytic nature of neurons is required to sustain higher-order organismal functions., E. Prieto-García was a recipient of a position by the Fondo Social Europeo, Youth Employment Initiative, Junta de Castilla y León. Staff members (A. Rocher, H. Kulyk, N. Lager-Lachaud, L. Gales, F. Bellvert) of MetaToul (Toulouse, France, https://metatoul.fr) are gratefully acknowledged for technical support and access to MS facilities. The projects that gave rise to these results were funded by MICIU/AEI (PID2022-138813OB-I00, PID2019-105699RB-I00/10.13039/501100011033 and FEDER, UE to J.P.B.; SAF2017-90794-REDT to A.A.), la Caixa Foundation (grant agreement LCF/PR/HR23/52430016 to J.P.B.), the Instituto de Salud Carlos III (CB16/10/00282 to J.P.B.; PI21/00727, RD16/0019/0018, PMP22/00084 to A.A.), the Junta de Castilla y León (CSI011P23 and Escalera de Excelencia CLU-2017-03 to J.P.B. and A.A.) and the European Union’s Horizon Europe research and innovation programme under MSCA Doctoral Networks 2021 (101072759, FuEl ThE bRaiN In healtThY aging and age-related diseases (ETERNITY), to J.P.B. and A.A.). MetaToul is part of the national infrastructure MetaboHUB and is funded by the French National Research Agency (ANR) with grant number MetaboHUB-ANR-11-INBS-0010., Peer reviewed